These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9378845)

  • 21. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
    Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT
    Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High dose transdermal nicotine therapy for heavy smokers: safety, tolerability and measurement of nicotine and cotinine levels.
    Fredrickson PA; Hurt RD; Lee GM; Wingender L; Croghan IT; Lauger G; Gomez-Dahl L; Offord KP
    Psychopharmacology (Berl); 1995 Dec; 122(3):215-22. PubMed ID: 8748390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine.
    Benowitz NL; Zevin S; Jacob P
    J Pharmacol Exp Ther; 1998 Dec; 287(3):958-62. PubMed ID: 9864279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of nicotine chewing gum on plasma nicotine levels of cigarette smokers.
    Ebert RV; McNabb ME; Snow SL
    Clin Pharmacol Ther; 1984 Apr; 35(4):495-8. PubMed ID: 6705447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerability of concurrent use of nicotine gum and smoking in healthy volunteers.
    Stahl MM; Wohlfart B; Pahlm O
    Nicotine Tob Res; 2001 May; 3(2):157-65. PubMed ID: 11403730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of transdermal nicotine on tobacco/nicotine abstinence and the effects of a concurrently administered cigarette in women and men.
    Kleykamp BA; Jennings JM; Sams C; Weaver MF; Eissenberg T
    Exp Clin Psychopharmacol; 2008 Apr; 16(2):99-112. PubMed ID: 18489014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A transdermal nicotine patch is not effective for postoperative pain management in smokers: a pilot dose-ranging study.
    Olson LC; Hong D; Conell-Price JS; Cheng S; Flood P
    Anesth Analg; 2009 Dec; 109(6):1987-91. PubMed ID: 19923530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of high dose transdermal nicotine replacement in cigarette smokers.
    Hatsukami D; Mooney M; Murphy S; LeSage M; Babb D; Hecht S
    Pharmacol Biochem Behav; 2007 Jan; 86(1):132-9. PubMed ID: 17267026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma nicotine levels after cigarette smoking and chewing nicotine gum.
    Russell MA; Feyerabend C; Cole PV
    Br Med J; 1976 May; 1(6017):1043-6. PubMed ID: 1268547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The bioequivalent and effect of nicotine formulation gum on smoking cessation.
    Tundulawessa Y; Yongchaiyud P; Chutrthong W; Tundulawessa K
    J Med Assoc Thai; 2010 May; 93(5):574-9. PubMed ID: 20524443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicotine administration in rabbits using Habitrol nicotine patches and nicotine nasal spray.
    Sipe RV; Buck DC; Hollinger JO
    Clin Exp Pharmacol Physiol; 2000 Jul; 27(7):480-2. PubMed ID: 10874502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of plasma concentrations of nicotine and cotinine during cigarette smoking and transdermal nicotine treatment.
    Gourlay SG; Benowitz NL; Forbes A; McNeil JJ
    Eur J Clin Pharmacol; 1997; 51(5):407-14. PubMed ID: 9049583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the nicotine pharmacokinetics of Nicoderm (nicotine transdermal system) and half-hourly cigarette smoking.
    Gupta SK; Hwang SS; Causey D; Rolf CN; Gorsline J
    J Clin Pharmacol; 1995 Oct; 35(10):985-9. PubMed ID: 8568016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomised double-blind crossover trial of the potential analgesic effect of a transdermal nicotine patch in non-smokers based on objective and subjective assessment.
    Fukada T; Iwakiri H; Ozaki M
    Eur J Anaesthesiol; 2011 Aug; 28(8):592-6. PubMed ID: 21681103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physical exercise increases plasma concentrations of nicotine during treatment with a nicotine patch.
    Klemsdal TO; Gjesdal K; Zahlsen K
    Br J Clin Pharmacol; 1995 Jun; 39(6):677-9. PubMed ID: 7654487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid absorption of nicotine from new nicotine gum formulations.
    Shiffman S; Cone EJ; Buchhalter AR; Henningfield JE; Rohay JM; Gitchell JG; Pinney JM; Chau T
    Pharmacol Biochem Behav; 2009 Jan; 91(3):380-4. PubMed ID: 18762208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single- and multiple-dose pharmacokinetics of Nicoderm (Nicotine Transdermal System).
    Gupta SK; Okerholm RA; Coen P; Prather RD; Gorsline J
    J Clin Pharmacol; 1993 Feb; 33(2):169-74. PubMed ID: 8440767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular effects of transdermal nicotine in mildly hypertensive smokers.
    Tanus-Santos JE; Toledo JC; Cittadino M; Sabha M; Rocha JC; Moreno H
    Am J Hypertens; 2001 Jul; 14(7 Pt 1):610-4. PubMed ID: 11465642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized, double-blind, placebo-controlled study of transdermal nicotine patch for smoking cessation.
    Perng RP; Hsieh WC; Chen YM; Lu CC; Chiang SJ
    J Formos Med Assoc; 1998 Aug; 97(8):547-51. PubMed ID: 9747065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nicotine delivery to users from cigarettes and from different types of e-cigarettes.
    Hajek P; Przulj D; Phillips A; Anderson R; McRobbie H
    Psychopharmacology (Berl); 2017 Mar; 234(5):773-779. PubMed ID: 28070620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.